BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 25541039)

  • 21. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.
    Ren Q; Ma M; Yang J; Nonaka R; Yamaguchi A; Ishikawa KI; Kobayashi K; Murayama S; Hwang SH; Saiki S; Akamatsu W; Hattori N; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5815-E5823. PubMed ID: 29735655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease.
    Yun HM; Choi DY; Oh KW; Hong JT
    Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
    Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
    Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ethanolic extract of Bacopa monnieri against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mice model via inhibition of apoptotic pathways of dopaminergic neurons.
    Singh B; Pandey S; Yadav SK; Verma R; Singh SP; Mahdi AA
    Brain Res Bull; 2017 Oct; 135():120-128. PubMed ID: 29032054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.
    Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC
    Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Mattson MP
    J Neurosci Res; 1999 Jul; 57(2):195-206. PubMed ID: 10398297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model.
    Ahn EH; Kim DW; Shin MJ; Kim YN; Kim HR; Woo SJ; Kim SM; Kim DS; Kim J; Park J; Eum WS; Hwang HS; Choi SY
    Free Radic Biol Med; 2013 Feb; 55():36-45. PubMed ID: 23178948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical findings in the MPTP model of Parkinson's disease.
    Schmidt N; Ferger B
    J Neural Transm (Vienna); 2001; 108(11):1263-82. PubMed ID: 11768626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment.
    Korecka JA; Eggers R; Swaab DF; Bossers K; Verhaagen J
    Restor Neurol Neurosci; 2013; 31(2):155-67. PubMed ID: 23271419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease.
    Hu K; Huang Q; Liu C; Li Y; Liu Y; Wang H; Li M; Ma S
    Neuroscience; 2019 Feb; 399():117-124. PubMed ID: 30590105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.
    Muñoz-Manchado AB; Villadiego J; Romo-Madero S; Suárez-Luna N; Bermejo-Navas A; Rodríguez-Gómez JA; Garrido-Gil P; Labandeira-García JL; Echevarría M; López-Barneo J; Toledo-Aral JJ
    J Neurochem; 2016 Jan; 136(2):373-87. PubMed ID: 26500044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.